Fierce Biotech and New Product Planning Summits
Our team will be on the ground at the co-located Fierce Biotech and New Product Planning Summits to discuss strategic and operational challenges in clinical development, as well as strategies to help biopharma companies achieve the highest probability of commercial success.
FEATURED PRESENTATION: NEW PRODUCT PLANNING SUMMIT
September 19 | 9:30am ET
|
Thinking Differently About Indication Prioritization This session will introduce a new and robust framework for indication prioritization that has resulted in more balanced and actionable assessments of individual indications by focusing not only on feasibility, but also post launch differentiation and value creation. Case studies will illustrate how this change in approach has improved decision making and higher corporate valuations with less risk. |
Waynne Waterfield
Managing Director, |
FEATURED PRESENTATION: FIERCE BIOTECH SUMMIT
September 20 | 11:30am ET
|
Separating Fact from Fiction: Decentralized Clinical Trials (DCTs) in the Biotech Space Common misconceptions surrounding decentralized research often deter sponsors from attaining its key benefits. Separating fact from fiction and understanding how to identify fit for purpose solutions can lay the roadmap for successful implementation of a DCT strategy. This session will focus on “myth busting” these common misconceptions and provide an overview of the benefits decentralization can bring to biotechs. |
Sarah Gillespie
Associate Director, |
Learn more about our capabilities:
Specialized Solutions for Biotech
